Search Results - "Bouwer, N. I."
-
1
Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring?
Published in Breast cancer research and treatment (01-04-2021)“…Purpose Patients with HER2-positive metastatic breast cancer (MBC) usually receive many years of trastuzumab treatment. It is unknown whether these patients…”
Get full text
Journal Article -
2
Radiological complete remission in HER2-positive metastatic breast cancer patients: what to do with trastuzumab?
Published in Breast cancer research and treatment (01-12-2019)“…Purpose Patients with HER2-positive metastatic breast cancer (MBC) treated with trastuzumab may experience durable tumor response for many years. It is unknown…”
Get full text
Journal Article -
3
2D-echocardiography vs cardiac MRI strain using deep learning: a prospective cohort study in patients with HER2-positive breast cancer undergoing trastuzumab
Published in European heart journal cardiovascular imaging (08-02-2021)“…Abstract Funding Acknowledgements Type of funding sources: Private hospital(s). Main funding source(s): Promotiefonds Albert Schweitzer Hospital Background…”
Get full text
Journal Article -
4
Abstract P6-17-19: What to do with trastuzumab therapy after achieving radiological complete remission (rCR) in HER2+ metastatic breast cancer (MBC)?
Published in Cancer research (Chicago, Ill.) (15-02-2019)“…Abstract Intro MBC is generally considered incurable, but patients with HER2+ disease treated with trastuzumab do relatively well and some have an exceptional…”
Get full text
Journal Article